Information Provided By:
Fly News Breaks for September 19, 2019
LGND
Sep 19, 2019 | 04:48 EDT
Barclays analyst Balaji Prasad upgraded Ligand Pharmaceuticals to Overweight from Equal Weight and raised his price target for the shares to $132 from $110.
News For LGND From the Last 2 Days
There are no results for your query LGND